KLRC1 and hepatocellular carcinoma: In NK cells of hepatocellular carcinoma (HCC) patients it was suggested that miRNA-182 may augment NK-cell cytotoxicity against liver cancer through perforin-1 up-regulation and by modulating NKG2D and NKG2A expressions [121].